logo-loader
FinanceFinancial Services
Daniel Stewart

Rumoured Rob Terry stake hike sends Daniel Stewart higher

Rob Terry’s investment vehicle, Quob Park Estate, has a 9.99% stake in the AIM-listed stockbroker.

dollar-FX-(Resized).jpg
Shares in Daniel Stewart rose 0.3p to 1.75p today.

Shares in Daniel Stewart Securities (LON:DAN) surged more than 20% today amid hopes that the former Quindell boss could look to up his stake in the broker.

Rob Terry’s investment vehicle, Quob Park Estate, has a 9.99% stake in the AIM-listed stockbroker.

It has not been able to extend this due to restrictions put in place by the Financial Conduct Authority (FCA) while it conducted a probe into Quindell.

But the FCA dropped its investigation this morning to make way for the Serious Fraud Office (SFO), sParking speculation that Terry might soon raise his stake in Daniel Stewart.

However, this seems unlikely in the near term at least. For Quob Park said on August  5 that it "would not plan to gain FCA approval" for further shares purchases until ALL investigations in Quindell are finished, including the SFO probe.

Terry’s Quob Park also has 12% stake in Imaginatik (LON:IMTK).

Shares in Daniel Stewart rose 0.3p to 1.75p today.

Quick facts: Daniel Stewart

Price: £0.00

Market: AIM
Market Cap: £0.00
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Scancell back in the clinic with a phase II trial of its...

Scancell Holdings PLC's (LON:SCLP) Cliff Holloway tells Proactive London's Andrew Scott they've begun the UK arm of the phase II trial of its flagship skin cancer treatment. The trial is testing the safety and efficacy of SCIB1 in metastatic melanoma patients who are also receiving Merck’s...

14 hours, 49 minutes ago

2 min read